BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28524160)

  • 21. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Helm O; Mennrich R; Petrick D; Goebel L; Freitag-Wolf S; Röder C; Kalthoff H; Röcken C; Sipos B; Kabelitz D; Schäfer H; Oberg HH; Wesch D; Sebens S
    PLoS One; 2014; 9(5):e94357. PubMed ID: 24797069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
    Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
    Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.
    Leo JM; Kalloger SE; Peixoto RD; Gale NS; Webber DL; Owen DA; Renouf D; Schaeffer DF
    J Clin Pathol; 2016 May; 69(5):431-9. PubMed ID: 26500334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression.
    Gundlach JP; Hauser C; Schlegel FM; Willms A; Halske C; Röder C; Krüger S; Röcken C; Becker T; Kalthoff H; Trauzold A
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3313-3324. PubMed ID: 34302528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
    Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma.
    Hristov AC; Cope L; Reyes MD; Singh M; Iacobuzio-Donahue C; Maitra A; Resar LM
    Mod Pathol; 2009 Jan; 22(1):43-9. PubMed ID: 18843278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer.
    Hu H; Hang JJ; Han T; Zhuo M; Jiao F; Wang LW
    Tumour Biol; 2016 Jul; 37(7):8657-64. PubMed ID: 26738860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
    Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment.
    Wong CW; Han HW; Tien YW; Hsu SH
    Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
    Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
    Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
    Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BAG3-positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma.
    Yuan Y; Jiang JY; Wang JM; Sun J; Li C; Liu BQ; Yan J; Meng XN; Wang HQ
    J Cell Mol Med; 2019 Aug; 23(8):5006-5016. PubMed ID: 31119886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
    Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
    Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
    J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue.
    Abe N; Watanabe T; Suzuki Y; Matsumoto N; Masaki T; Mori T; Sugiyama M; Chiappetta G; Fusco A; Atomi Y
    Br J Cancer; 2003 Dec; 89(11):2104-9. PubMed ID: 14647145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection.
    Drifka CR; Loeffler AG; Mathewson K; Keikhosravi A; Eickhoff JC; Liu Y; Weber SM; Kao WJ; Eliceiri KW
    Oncotarget; 2016 Nov; 7(46):76197-76213. PubMed ID: 27776346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors.
    Kang Y; Roife D; Lee Y; Lv H; Suzuki R; Ling J; Rios Perez MV; Li X; Dai B; Pratt M; Truty MJ; Chatterjee D; Wang H; Thomas RM; Wang Y; Koay EJ; Chiao PJ; Katz MH; Fleming JB
    Clin Cancer Res; 2016 Oct; 22(19):4934-4946. PubMed ID: 27126993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
    Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
    J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.